Empirico

Genetics-Based Drug Discovery

Additional undisclosed programs RD immune conditions, dermatological conditions, ophthalmic conditions

Empirico is using human genetics to create next-generation therapeutics. With advances in DNA sequencing, human genetics can now be employed to gain new biological insights for medicine development. Using this approach with programmable biology, Empirico is powering novel target discovery and development. This involves comparing genetic data with health information from millions of individuals to learn about the role of genes and proteins in health and disease. To facilitate discovery, Empirico uses their Precision Insights PlatformTM, a machine learning platform that can interrogate and prioritize high-confidence therapeutics. Candidates are then validated experimentally in Empirico’s lab.